- Home
- WASH vs EYPT Comparison
WASH vs EYPT Comparison
Compare WASH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- EYPT
- Stock Information
- Founded
- WASH 1800
- EYPT 1987
- Country
- WASH United States
- EYPT United States
- Employees
- WASH N/A
- EYPT N/A
- Industry
- WASH Major Banks
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- WASH Finance
- EYPT Industrials
- Exchange
- WASH Nasdaq
- EYPT Nasdaq
- Market Cap
- WASH 623.4M
- EYPT 489.4M
- IPO Year
- WASH N/A
- EYPT 2005
- Fundamental
- Price
- WASH $32.52
- EYPT $7.69
- Analyst Decision
- WASH Hold
- EYPT Strong Buy
- Analyst Count
- WASH 2
- EYPT 8
- Target Price
- WASH $34.00
- EYPT $25.71
- AVG Volume (30 Days)
- WASH 205.0K
- EYPT 665.0K
- Earning Date
- WASH 01-29-2025
- EYPT 03-06-2025
- Dividend Yield
- WASH 6.78%
- EYPT N/A
- EPS Growth
- WASH N/A
- EYPT N/A
- EPS
- WASH N/A
- EYPT N/A
- Revenue
- WASH $98,251,000.00
- EYPT $45,713,000.00
- Revenue This Year
- WASH N/A
- EYPT N/A
- Revenue Next Year
- WASH $10.09
- EYPT N/A
- P/E Ratio
- WASH N/A
- EYPT N/A
- Revenue Growth
- WASH N/A
- EYPT 7.50
- 52 Week Low
- WASH $24.11
- EYPT $6.90
- 52 Week High
- WASH $40.59
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- WASH 48.04
- EYPT 41.66
- Support Level
- WASH $30.79
- EYPT $7.58
- Resistance Level
- WASH $32.89
- EYPT $8.16
- Average True Range (ATR)
- WASH 0.99
- EYPT 0.55
- MACD
- WASH 0.19
- EYPT -0.07
- Stochastic Oscillator
- WASH 57.22
- EYPT 3.06
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.